Xenobiotic Stress Induces Hepatomegaly and Liver Tumors via the Nuclear Receptor Constitutive Androstane Receptor
Open Access
- 1 June 2005
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 19 (6) , 1646-1653
- https://doi.org/10.1210/me.2004-0520
Abstract
The constitutive androstane receptor (CAR, NR1I3) is a central regulator of xenobiotic metabolism. CAR activation induces hepatic expression of detoxification enzymes and transporters and increases liver size. Here we show that CAR-mediated hepatomegaly is a transient, adaptive response to acute xenobiotic stress. In contrast, chronic CAR activation results in hepatocarcinogenesis. In both acute and chronic xenobiotic responses, hepatocyte DNA replication is increased and apoptosis is decreased. These effects are absent in CAR null mice, which are completely resistant to tumorigenic effects of chronic xenobiotic stress. In the acute response, direct up-regulation of Mdm2 expression by CAR contributes to both increased DNA replication and inhibition of p53-mediated apoptosis. These results demonstrate an essential role for CAR in regulating both liver homeostasis and tumorigenesis in response to xenobiotic stresses, and they also identify a specific molecular mechanism linking chronic environmental stress and tumor formation.Keywords
This publication has 36 references indexed in Scilit:
- The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced HepatotoxicityJournal of Biological Chemistry, 2004
- The Orphan Nuclear Receptor Constitutive Active/Androstane Receptor Is Essential for Liver Tumor Promotion by Phenobarbital in MiceCancer Research, 2004
- Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesionsCarcinogenesis: Integrative Cancer Research, 2003
- MDM2: life without p53Trends in Genetics, 2001
- Early Increase in Cyclin-D1 Expression and Accelerated Entry of Mouse Hepatocytes into S Phase after Administration of the Mitogen 1,4-Bis[2-(3,5-Dichloropyridyloxy)] BenzeneThe American Journal of Pathology, 2000
- Fractionation of Rat Hepatocyte Subpopulations with Varying Metabolic Potential, Proliferative Capacity, and Retroviral Gene Transfer EfficiencyExperimental Cell Research, 1998
- Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotionPharmacology & Therapeutics, 1996
- Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamineCarcinogenesis: Integrative Cancer Research, 1992
- The effect of the format of administration and the total dose of phenobarbital on altered hepatic foci following initiation in female rats with diethylnitrosamineCarcinogenesis: Integrative Cancer Research, 1991
- Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promotersCarcinogenesis: Integrative Cancer Research, 1984